AMNEAL PHARMS FDA Approval ANDA 211139

ANDA 211139

AMNEAL PHARMS

FDA Drug Application

Application #211139

Documents

Letter2018-12-20

Application Sponsors

ANDA 211139AMNEAL PHARMS

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL5MG0AMPHETAMINE SULFATEAMPHETAMINE SULFATE
002TABLET;ORAL10MG0AMPHETAMINE SULFATEAMPHETAMINE SULFATE

FDA Submissions

UNKNOWN; ORIG1AP2018-09-26STANDARD
LABELING; LabelingSUPPL4AP2022-02-10STANDARD
LABELING; LabelingSUPPL5AP2022-02-25STANDARD

Submissions Property Types

ORIG1Null15
SUPPL4Null7
SUPPL5Null7

TE Codes

001PrescriptionAA
002PrescriptionAA

CDER Filings

AMNEAL PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211139
            [companyName] => AMNEAL PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMPHETAMINE SULFATE","activeIngredients":"AMPHETAMINE SULFATE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"AMPHETAMINE SULFATE","activeIngredients":"AMPHETAMINE SULFATE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/26\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/211139Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-09-26
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.